Mend is a Long Island City-based health-tech startup that offers a combined platform of high-quality nutritional supplements and technology-enabled remote monitoring tools aimed at improving patient outcomes in concierge medicine. Its products allow users to proactively track and enhance their health while receiving personalized dietary support. The company positions itself at the intersection of nutrition and digital health, targeting partnerships with surgical practices to embed its offerings in post-operative and long-term care regimes. Following its recent capital influx, Mend plans to broaden its supplement portfolio and scale its telehealth infrastructure. The leadership also intends to deepen integrations with clinical partners to capture a larger share of the growing personalized wellness market. The Series A financing underscores strong investor confidence in the firm’s ability to innovate within the nutrition and remote-care sectors. No revenue or user metrics were disclosed in the article, but the new funds provide runway to accelerate product development and market expansion.

Total raised

$35M

Funding rounds

2

Latest round

Series A

Latest activity

Dec 2025